CVS Group (CVSG) Share Price, News & Analysis

Company Overview

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste disposal services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.

Key Stats

• Today's Range: 1,192 to 1,224
• 50-Day Range: 1,194 to 1,292
• 52-Week Range: 791 to 1,342
• Volume: 138,510 shs
• Average Volume: 302,953 shs
• Market Capitalization: £865.18 million
• P/E Ratio: 31,736.84
• Dividend Yield: 0.01%
• Price Target: GBX 1,750
• Consensus Rating: Buy

CVS Group Stock Analysis - MarketRank™

CVS Group scored higher than 41% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

CVS Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

CVS Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of CVS Group is 31,736.84, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 269.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of CVS Group is 31,736.84, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 494.42.

Price to Earnings Growth Ratio

CVS Group has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

CVS Group has a P/B Ratio of 3.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CVSG.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

CVS Group has a dividend yield of 0.65%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

CVS Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of CVS Group is 210.53%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for CVSG.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.20

News Sentiment

CVS Group has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Consumer Cyclical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for CVS Group this week, compared to 1 article on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, CVS Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought £19,991.04 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

Only 1.37% of the stock of CVS Group is held by insiders.

Percentage Held by Institutions

48.54% of the stock of CVS Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CVSG Stock Analysis - Frequently Asked Questions

How have CVSG shares performed this year?

CVS Group's stock was trading at GBX 840 at the beginning of the year. Since then, CVSG shares have increased by 43.6% and is now trading at GBX 1,206.

How were CVS Group's earnings last quarter?

CVS Group plc (LON:CVSG) issued its quarterly earnings data on Thursday, February, 27th. The company reported $40.00 earnings per share (EPS) for the quarter. CVS Group had a trailing twelve-month return on equity of 7.86% and a net margin of 3.20%.

How do I buy shares of CVS Group?

Shares of CVSG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of CVS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Group investors own include Meta Platforms (META), Salesforce (CRM), NVIDIA (NVDA), Pfizer (PFE), QUALCOMM (QCOM), AbbVie (ABBV) and Walt Disney (DIS).

Company Calendar

• Last Earnings: 2/27/2025
• Today: 9/03/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Cyclical
• Industry: Personal Services
• Sub-Industry: N/A
• Current Symbol: LON:CVSG
• CIK: N/A
• Web: www.cvsukltd.co.uk
• Phone: +44-1379-644288
• Fax: N/A
• Employees: 9,100
• Year Founded: N/A

Price Target and Rating

• Average Price Target for CVS Group: GBX 1,750
• High Price Target: GBX 2,000
• Low Price Target: GBX 1,500
• Potential Upside/Downside: +45.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 0.04
• Trailing P/E Ratio: 31,736.84
• Forward P/E Ratio: 12.84
• P/E Growth: 1.77
• Net Income: £20.68 million
• Net Margins: 3.20%
• Pretax Margin: N/A
• Return on Equity: 7.86%
• Return on Assets: 5.03%

Debt

• Debt-to-Equity Ratio: 110.52
• Current Ratio: 1.09
• Quick Ratio: 0.90

Sales & Book Value

• Annual Sales: £668.60 million
• Price / Sales: 1.29
• Cash Flow: GBX 39.76 per share
• Price / Cash Flow: 30.33
• Book Value: GBX 363.16 per share
• Price / Book: 3.32

Miscellaneous

• Outstanding Shares: 71,740,000
• Free Float: N/A
• Market Cap: £865.18 million
• Optionable: Not Optionable
• Beta: 1.02